Glenn Polyak thought he was out of options when his Stage 4 melanoma spread to his brain, until he became only the second Banner Health patient to receive an innovative new cell therapy treatment.
The Eastern Arizona man had been battling cancer for years, and doctors told him his dangerous melanoma mutation made his condition nearly untreatable.
In 2024, tumor-infiltrating lymphocyte (TIL) therapy emerged. It’s the first and only FDA-approved treatment for metastatic melanoma tumors which are non-responsive to other treatments or cannot be taken out…